Latanoprost acid

Overview

Latanoprost acid, an analog of prostaglandin (PG) F2α, is an selective prostanoid receptor ( FP ) agonist that specifically activates the FP-PG receptor. Latanoprost acid inhibits RANKL-induced osteoclastgenesis and function by inhibiting ERK , AKT , JNK , and p38 cascade, following by the c-fos/NFATc1 pathway. Latanoprost acid is a medication which works to lower pressure inside the eyes.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > p38 MAPK | Products > Signaling Pathways > Prostaglandin Receptor | Products > Signaling Pathways > ERK | Products > Signaling Pathways > Akt | Products > Signaling Pathways > JNK

Product Information

• Catalog No.: HY-113756A
• CAS No.: 41639-83-2
• Molecular Formula: C23H34O5
• Molecular Weight: 390.51
• Purity: 98.77%
• Storage: Pure form -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 2.5 mg/mL (6.40 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source